The move could open new avenues for medical research, change how the drug is regulated and reduce a hefty tax burden on the ...

President Donald Trump has directed his administration to pursue reclassifying marijuana as a less dangerous drug.

The reclassification would move marijuana away from its current classification as a Schedule I drug, alongside heroin and LSD ...

The change would not legalize the drug on the federal level, but would ease barriers on research using cannabis.

U.S. President Donald Trump on Thursday was set to sign an order recommending the loosening of federal regulations on ...

President Trump’s Executive Order on rescheduling marijuana caps a year of major cannabis law changes. Learn how employers ...

Cannabis companies like Tilray Brands and Canopy Growth could soon face a more mellow path ahead following President Donald ...

HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) ('HYTN” or the 'Company”), a pharmaceutical-grade cannabis ...

The reclassification from Schedule I to Schedule III could transform cannabis banking while leaving state-legal markets intact.